|本期目录/Table of Contents|

[1]燕朝均,于凤旭,廖斌.血清尿酸与风湿性心脏病患者心房颤动的关系[J].医学研究与战创伤救治(原医学研究生学报),2017,19(03):293-297.[doi:10.3969/j.issn.1672-271X.2017.03.018]
点击复制

血清尿酸与风湿性心脏病患者心房颤动的关系()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第19卷
期数:
2017年03期
页码:
293-297
栏目:
出版日期:
2017-05-20

文章信息/Info

Title:
-
作者:
燕朝均; 于凤旭; 廖斌
作者单位：646000泸州，西南医科大学附属医院胸心外科
Author(s):
-
关键词:
血清尿酸; 风湿性心脏病; 心房颤动
Keywords:
-
分类号:
R605;R453
DOI:
10.3969/j.issn.1672-271X.2017.03.018
文献标志码:
B
摘要:
目的 通过分析风湿性心脏病（风心病）合并心房颤动（房颤）患者的血清尿酸水平（尿酸），探讨血清尿酸水平与风湿性心脏病患者心房颤动的关系。方法 回顾性分析334例住院的风湿性心脏病患者，根据有无房颤分为风心病房颤组(240例)、风心病窦性心律组(94例)，比较2组的一般资料、临床资料、心脏彩超数据。结果 风心病伴房颤组的血清尿酸、肌酐、尿素、左心房内径(LAD)均明显高于风心病窦性心律组(P<0.05)，白蛋白、高密度脂蛋白胆固醇、总胆固醇、性别比例、左心室射血分数(LVEF)均明显低于风心病窦性心律组(P<0.05)。逐步logistic回归分析矫正了尿酸、肌酐、尿素、LAD、性别比例、白蛋白、高密度脂蛋白胆固醇、总胆固醇及LVEF的影响后，尿酸(OR:1.008;95%CI:1.004～1.012;P<0.001)、肌酐(OR:1.038;95%CI:1.008～1.070;P=0.012)、左心房内径(OR:1.040;95%CI:1.006～1.075;P=0.019)、左心室射血分数(OR:0.952;95%CI:0.909～0.998;P=0.040 )与风心病患者房颤的发生显著相关。结论 血清尿酸水平升高是风湿性心脏病患者心房颤动发生的高危险因素，重视早期控制尿酸水平，对预防心房重塑及房颤的发生和发展有一定的临床指导作用。
Abstract:
-

参考文献/References:

[1]Iguchi Y,Kimura K,Aoki J,et al.Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city [J]. Circ J,2008,72(6):909-913.
[2]Numa S,Hirai T,Nakagawa K,et al.Hyperuricemia and transesophageal echocardiographic thromboembolic risk in patients with atrial fibrillation at clinically low-intermediate risk [J]. Circ J,2014,78(7):1600-1605.
[3]Ferrari R，Bertini M，Blomstrom-Lundqvist C, et al.An update on atrial fibrillation in 2014: From pathophysiology to treatment [J]. Int J Cardiol,2016,203(1)：22-29.
[4]易茜，蹇朝，李勇，等.氧化应激标志物在房颤患者心房结构重构中的变化及意义 [J]. 第三军医大学学报,2015,37(1)：55-59.
[5]Hu YF,Chen YJ,Lin YJ,et al.Inflammation and the pathogenesis of atrial fibrillation [J]. Nat Rev Cardiol,2015,12(4)：230-243.
[6]Harada M,Van Wagoner DR,Nattel S.Role of inflammation in atrial fibrillation pathophysiology and management [J]. Circ J,2015,79(3)：495-502.
[7]Feig DI，Kang DH，Johnson RJ. Uric acid and cardiovascular risk [J]. N Engl J Med,2008,359(17)：1811-1821.
[8]Bombelli M, Ronchi I, Volpe M, et al. Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality [J]. J Hypertens, 2014,32(6):1237-1244.
[9]Tekin G,Tekin YK,Erbay AR,et al.Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure [J]. Angiology,2013,64(4)：300-303.
[10]Ndrepepa G, Braun S, King L, et al. Association of uric acid with mortality in patients with stable coronary artery disease [J]. Metabolism, 2012,61(12):1780-1786.
[11]Nyrnes A,Toft I,Mathiesen EB,et al.Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women--the Tromso Study [J]. Europace,2014,16(3)：320-326.
[12]Tamariz L, Agarwal S, Soliman EZ, et al. Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study) [J]. Am J Cardiol, 2011,108(9):1272-1276.
[13]Dudley SC,Hoch NE,McCann LA,et al.Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases [J]. Circ J,2005,112(9)：1266-1273.
[14]Liu Y,Liu H,Dong L,et al.Prevalence of atrial fibrillation in hospitalized patients over 40 years old: ten-year data from the Peoples Hospital of Peking University [J]. Acta Cardiol,2010,65(2)：221-224.
[15]Letsas KP, Korantzopoulos P, Filippatos GS,et al.Uric acid elevation in atrial fibrillation [J]. Hellenic J Cardiol,2010,51(3)：209-213.
[16]Koide Y，Yotsukura M，Sakata K,et al.Investigation of the predictors of transition to persistent atrial fibrillation in patients with paroxysmal atrial fibrillation [J]. Clin Cardiol,2002,25(2)：69-75.
[17]Parkash R,Green MS,Kerr CR,et al.The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation [J]. Am Heart J,2004,148(4)：649-654.
[18]Wozakowska-Kapon B.Changes in left atrial size in patients with persistent atrial fibrillation: a prospective echocardiographic study with a 5-year follow-up period [J]. Int J Cardiol,2005,101(1)：47-52.

相似文献/References:

备注/Memo

备注/Memo:
基金项目：四川省科技厅项目（Z14018）
更新日期/Last Update: 2017-05-20